Principal Financial Group Inc Bioventus Inc. Transaction History
Principal Financial Group Inc
- $176 Billion
- Q2 2025
A detailed history of Principal Financial Group Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 25,321 shares of BVS stock, worth $171,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,321
Previous 19,655
28.83%
Holding current value
$171,423
Previous $179,000
6.7%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BVS
# of Institutions
147Shares Held
49.3MCall Options Held
85.1KPut Options Held
13K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$88.2 Million30.91% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$47 Million19.48% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.28MShares$35.8 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$16.1 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $417M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...